Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-10-16

Clinical Trial Update: A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating pancreatic endocrine cell clusters implanted into the omentum for Type 1 diabetes patients with severe hypoglycemia has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pancreatic Endocrine Cell Clusters (pancreatic endocrine cell clusters)

Snippet

Sponsor: Seraxis | Conditions: Diabetes Mellitus Type 1 | Phase 1, Phase 2 | Status: WITHDRAWN